Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|1|257-261

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.1, 2015-01, pp. : 257-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor activity of combination treatment with gefitinib and docetaxel in EGFRTKIsensitive, primary resistant and acquired resistant human nonsmall cell lung cancer cells

By        

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2417-2422

Spandidos Publications

Access to resources Recommend Favorite

Crotoxin suppresses the tumorigenic properties and enhances the antitumor activity of Iressa® (gefinitib) in human lung adenocarcinoma SPCA1 cells

By  

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3009-3014

Spandidos Publications

Access to resources Recommend Favorite

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib

By Wang Fenghua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 331-335

Humana Press, Inc

Access to resources Recommend Favorite

Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer

By                    

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3629-3634

Spandidos Publications

Access to resources Recommend Favorite

Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance

By Ayed-Guerfali Dorra   Hassairi Basma   Khabir Abdelmajid   Sellami-Boudawara Tahia   Gargouri Ali   Mokdad-Gargouri Raja  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1775-1783

Springer Publishing Company

Access to resources Recommend Favorite